Back
Avidity Biosciences Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
RNA
Avidity Biosciences
Last Price:
$31.68
Seasonality Move:
28.99%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight buying pressure.
Avidity Biosciences Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.21 | Buy |
20-day SMA: | 30.06 | Buy |
50-day SMA: | 29.51 | Buy |
200-day SMA: | 36.79 | Sell |
8-day EMA: | 29.53 | Buy |
20-day EMA: | 29.42 | Buy |
50-day EMA: | 29.76 | Buy |
200-day EMA: | 32.29 | Sell |
Avidity Biosciences Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 52.89 | Buy |
Chaikin Money Flow: | 31987 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.28 - 31.58) | Buy |
Bollinger Bands (100): | (27.88 - 32.62) | Sell |
Avidity Biosciences Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Avidity Biosciences Stock
Is Avidity Biosciences Stock a Buy?
-
Avidity Biosciences share price is 30.22 while RNA 8-day simple moving average is 29.21, which is a Buy signal.
-
The stock price of RNA is 30.22 while Avidity Biosciences 20-day SMA is 30.06, which makes it a Buy.
-
Avidity Biosciences 50-day simple moving average is 29.51 while RNA share price is 30.22, making it a Buy technically.
-
RNA stock price is 30.22 and Avidity Biosciences 200-day simple moving average is 36.79, creating a Sell signal.
RNA Technical Analysis vs Fundamental Analysis
Sell
47
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy or a Sell?
-
Avidity Biosciences stock is rated a SellThe current Avidity Biosciences [RNA] share price is $30.22. The Score for RNA is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Avidity Biosciences Stock Info
Market Cap:
3.6B
Price in USD:
30.22
Share Volume:
1.3M
Avidity Biosciences 52-Week Range
52-Week High:
56.00
52-Week Low:
21.51
Sell
47
Avidity Biosciences (RNA)
is a Sell
Avidity Biosciences Share Price Forecast
-
What is the Avidity Biosciences stock price today?The Avidity Biosciences stock price is 30.22 USD today.
-
Will RNA stock go up or go down?Avidity Biosciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Avidity Biosciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Avidity Biosciences is overvalued.
Is Avidity Biosciences Stock a Buy?
-
Avidity Biosciences share price is 30.22 while RNA 8-day exponential moving average is 29.53, which is a Buy signal.
-
The stock price of RNA is 30.22 while Avidity Biosciences 20-day EMA is 29.42, which makes it a Buy.
-
Avidity Biosciences 50-day exponential moving average is 29.76 while RNA share price is 30.22, making it a Buy technically.
-
RNA stock price is 30.22 and Avidity Biosciences 200-day simple moving average is 32.29, creating a Sell signal.
Fundamental Analysis of Avidity Biosciences
Is Avidity Biosciences a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.13 per share, a decrease this year of $1.11 per share, and a decrease next year of $0.47 per share.
Technical Analysis of Avidity Biosciences
Should I short Avidity Biosciences stock?
-
RNA Moving Average Covergence Divergence (MACD) indicator is 0.07, suggesting Avidity Biosciences is a Buy
-
Avidity Biosciences Relative Strength Index (RSI) is 52.89, which suggest Avidity Biosciences is overbought
-
The Bollinger Bands (25) for Avidity Biosciences is (27.28 - 31.58), which suggest Avidity Biosciences is a Sell
-
The Bollinger Bands (100) for Avidity Biosciences is (27.88 - 32.62), which suggest Avidity Biosciences is a Sell
* Avidity Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.